These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 454975)

  • 1. A nucleotide with characteristic platelet aggregation and inhibition properties similar to 5-hydroxytryptamine [proceedings].
    Oppenheim B; Youdim MB
    Br J Pharmacol; 1979 May; 66(1):94P. PubMed ID: 454975
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Time-dependent potentiation and inhibition by 5-hydroxytryptamine of platelet aggregation induced by ADP.
    Michal F; Motamed M
    Br J Pharmacol; 1975 Jun; 54(2):221P-222P. PubMed ID: 1148513
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions between noradrenaline and 5-hydroxytryptamine involving platelet aggregation [proceedings].
    Ball SE; Boullin DJ; Glenton PA
    J Physiol; 1977 Oct; 272(1):98P-99P. PubMed ID: 592189
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intracellular signaling events in ADP-induced platelet aggregation.
    Daniel JL; Dangelmaier C; Jin J; Kim YB; Kunapuli SP
    Thromb Haemost; 1999 Oct; 82(4):1322-6. PubMed ID: 10544922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ; Brossmer R
    Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison between ADP-induced aggregation and noradrenaline plus 5-hydroxytryptamine induced aggregation.
    Takano S; Suzuki T
    Fukushima J Med Sci; 1978 Feb; 25(1-2):1-7. PubMed ID: 748135
    [No Abstract]   [Full Text] [Related]  

  • 10. A study of demembranated muscle fibers under equilibrium conditions.
    Tregear RT; Clarke ML; Marston SB; Rodger CD; Bordas J; Koch M
    Soc Gen Physiol Ser; 1982; 37():131-41. PubMed ID: 7146945
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
    Li BY; Zhou YC; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
    Ozdener F; Gülbas Z; Erol K; Ozdemir V
    Methods Find Exp Clin Pharmacol; 2005; 27(6):395-400. PubMed ID: 16179957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Human blood platelet aggregation induced by dopamine, 5-hydroxyptrypamine and analogues.
    Boullin DJ; Green AR; Grimes RP
    J Physiol; 1975 Nov; 252(2):46P-47P. PubMed ID: 1206539
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation.
    Shimizu M; Kanazawa K; Matsuda Y; Takai E; Iwai C; Miyamoto Y; Hashimoto M; Akita H; Yokoyama M
    Thromb Res; 2003; 112(3):137-42. PubMed ID: 14967409
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional expression of the amplification reaction between serotonin and epinephrine on platelets.
    De Clerck F; Xhonneux B; de Chaffoy de Courcelles D
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S1-5. PubMed ID: 2459505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of bencyclan on shear induced platelet aggregation (author's transl)].
    Klose HJ; Rieger H; Schmid-Schönbein H
    Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modulating effects of adenosine on the process of human platelet activation].
    Prokudin VIu; Melkova OM; Karaulov AV; Porodenko NV
    Biull Eksp Biol Med; 1992 Jun; 113(6):606-8. PubMed ID: 1446028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T; Lie RT; Holmsen H
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17beta-estradiol and medroxyprogesterone acetate in postmenopausal women.
    Bar J; Lahav J; Hod M; Ben-Rafael Z; Weinberger I; Brosens J
    Thromb Haemost; 2000 Oct; 84(4):695-700. PubMed ID: 11057872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.